A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.
The results are reported of a small clinical trial carried out to assess the potential value of the hypoxic cell radiosensitizer misonidazole in the radiation treatment of Grade 3 and 4 supratentorial astrocytomas. A total of 55 patients were randomly allocated to one of 3 treatment groups. No signi...
Main Authors: | Bleehen, N. M., Wiltshire, C. R., Plowman, P. N., Watson, J. V., Gleave, J. R., Holmes, A. E., Lewin, W. S., Treip, C. S., Hawkins, T. D. |
---|---|
Format: | Online |
Language: | English |
Published: |
1981
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010639/ |
Similar Items
-
Monitoring salivary misonidazole in man: a possible alternative to plasma monitoring.
by: Workman, P., et al.
Published: (1978) -
Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity.
by: Workman, P., et al.
Published: (1980) -
A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party.
by: Bleehen, N. M., et al.
Published: (1991) -
Interactions between misonidazole and hyperthermia in EMT6 spheroids.
by: Morgan, J. E., et al.
Published: (1981) -
The penetration of misonidazole into spontaneous canine tumours.
by: White, R. A., et al.
Published: (1979)